Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05900206 |
| Title | Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer (ARIADNE) |
| Acronym | ARIADNE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Karolinska University Hospital |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | SWE |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Skåne University Hospital | NOT_YET_RECRUITING | Malmö | 21428 | Sweden | Details | |
| Sankt Gorans Hospital | NOT_YET_RECRUITING | Stockholm | 11219 | Sweden | Details | |
| Stockholm Southern Hospital | NOT_YET_RECRUITING | Stockholm | 11861 | Sweden | Details | |
| Karolinska University Hospital | RECRUITING | Stockholm | 17164 | Sweden | Details | |
| Norrlands University Hospital | NOT_YET_RECRUITING | Umeå | 90185 | Sweden | Details | |
| Uppsala University Hospital | NOT_YET_RECRUITING | Uppsala | 75185 | Sweden | Details | |
| Örebro University Hospital | NOT_YET_RECRUITING | Örebro | 70185 | Sweden | Details |